Tibet Pharmaceuticals Stock Return On Equity
Tibet Pharmaceuticals fundamentals help investors to digest information that contributes to Tibet Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Tibet Stock. The fundamental analysis module provides a way to measure Tibet Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tibet Pharmaceuticals stock.
Tibet |
Tibet Pharmaceuticals Company Return On Equity Analysis
Tibet Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Tibet Pharmaceuticals Return On Equity | 0.32 |
Most of Tibet Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tibet Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Tibet Pharmaceuticals has a Return On Equity of 0.3215. This is 101.34% lower than that of the Pharmaceuticals sector and 100.16% lower than that of the Health Care industry. The return on equity for all United States stocks is notably lower than that of the firm.
Tibet Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tibet Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tibet Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tibet Pharmaceuticals by comparing valuation metrics of similar companies.Tibet Pharmaceuticals is currently under evaluation in return on equity category among its peers.
Tibet Fundamentals
| Return On Equity | 0.32 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.32 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | (25.96 M) | |||
| Shares Outstanding | 14.85 M | |||
| Revenue | 32.36 M | |||
| Gross Profit | 16.18 M | |||
| EBITDA | 11.53 M | |||
| Net Income | 13.14 M | |||
| Cash And Equivalents | 25.96 M | |||
| Cash Per Share | 1.75 X | |||
| Total Debt | 4.71 M | |||
| Current Ratio | 14.48 X | |||
| Book Value Per Share | 3.18 X | |||
| Cash Flow From Operations | 7.85 M | |||
| Earnings Per Share | 0.78 X | |||
| Number Of Employees | 190 | |||
| Beta | -15.29 | |||
| Market Capitalization | 14 | |||
| Total Asset | 28.2 M | |||
| Retained Earnings | 13.63 M | |||
| Working Capital | 41 M | |||
| Current Asset | 44 M | |||
| Current Liabilities | 3 M | |||
| Net Asset | 28.2 M |
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Tibet Stock
If you are still planning to invest in Tibet Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tibet Pharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |